fbpx

Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation.  Knowledge is Power!

Learn about conventional, complementary, and integrative therapies.

Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.

Click the orange button to the right to learn more.

Search Results for: overtreatment

Early Breast Cancer- Use Less Chemo- less “over-treatment?”

 From 2013 to 2015, keeping other factors constant, chemotherapy use (for breast cancer) was estimated to decline from 34.5% to 21.3%. A diagnosis of cancer is difficult, to say the least. However, an

Continue reading

DCIS treatment plan? Diagnose your risks further…

For women who have early breast tumors (DCIS) surgically removed, a genetic test may help predict the odds of a recurrence, a new study says Receiving a diagnosis of Ductal Carcinoma In Situ (DCIS)

Continue reading

Mammograms Identify DCIS But Lead to Over-diagnosis, Over-treatment?

“Breast cancer screening was not associated with any reduction in the incidence of advanced cancer, and overdiagnosis of invasive tumors and ductal carcinoma in situ is a common problem…” Articles

Continue reading

Prostate Cancer- Treat or Active Surveillance?

Evidence-based, Non-toxic Prostate Cancer Therapies Is Both Treatment And Active Surveillance A diagnosis of prostate cancer doesn’t really give you actionable information these days. It is the stage

Continue reading

Nutritional Therapies- DCIS

“Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer, such as soy, pomegranate, mangosteen, citrus fruits,

Continue reading

Are Endometrial Polyps Overtreated?

A "watch and wait" course of action for patients diagnosed with endometrial polyps may be the best course of action, recent studies show:  

Continue reading

Pre- Myeloma? Stage 1 Multiple Myeloma? Cure vs. Control

Should we treat patients with myeloma with multidrug, multitransplant combinations with the goal of potentially curing a subset of patients, recognizing that the risk of adverse events and effect on quality

Continue reading

Take Prostate Cancer Active Surveillance a step Further

The use of active surveillance increased from 14.5 percent to 42.1 percent of men with low-risk prostate cancer between 2010 and 2015, said the researchers... According to the study linked and excerpted

Continue reading

Financial Cost of DCIS Got You Worried? Read This

The cost of early stage breast cancer (DCIS) therapy is a concern that influences treatment decisions for many women, even when they have insurance and higher income… Though Ductal Carcinoma In-situ

Continue reading

Rename In-Situ, Pre-, IDLE, aka low-risk Cancer Now-

What we routinely refer to as cancer today is a disease ranging from ultra low risk (less than a 5% chance of progression over two decades) to extremely high (more than a 75% chance of progression over

Continue reading

Early Prostate Cancer- 60’s Gleason 3+3 PSA 7

“Curcumin could be a potentially therapeutic anti‐cancer agent, as it significantly inhibits prostate cancer growth, as exemplified by LNCaP in vivo, and has the potential…” Dear Cancer

Continue reading

Prostate cancer, gleason score, biopsy, conventional, non conventional?

Each of these therapies has a risk/reward scenario. Keep in mind that there is a long and growing list of evidence-based, non-toxic therapies to treat early prostate cancer. Dear Cancer Coach- I was wondering

Continue reading